Literature DB >> 29287779

Reply to: Central corneal thickness measurement with Cirrus HD-OCT and Topcon SP-3000P.

Jorge A Calvo-Sanz1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29287779      PMCID: PMC6039611          DOI: 10.1016/j.optom.2017.11.002

Source DB:  PubMed          Journal:  J Optom        ISSN: 1989-1342


× No keyword cloud information.
I would like to thank Dr. De Bernardo and colleagues for their words on our work on the analysis of central corneal thickness (CCT). We are honored to receive a comment of someone with such extensive research experience in this field. It is true that the effects of drugs used as anesthetics may affect CCT measurements. As De Bernardo cites in her letter, Osuagwu et al. described corneal thickening after Tetracaine 1% drop instillation, however, we must apply a certain clinical approach to statistical data. I quote the author: “In general, the central cornea was thicker by 3 μm and 4 μm in eyes measured with USP, 10 min after instillation of one drop of 1% tetracaine in session 1 and session 2, respectively.” These difference were statistically significant in the analysis performed by the authors, but the difference between the measurements obtained by the authors with Ultrasonic pachymetry or Topcon SP-3000P were 26–29 μm (values similar to those obtained in our study); Therefore, the existence of a 3 or 4 μm difference between the measurement with or without tetracaine in the USP, although statistically significant, is not clinically significant. We must also remember that these differences are lower than standard deviation and repeatability between SP3000P measures, which according to the authors was ±12 μm. The authors describe that differences in CCT measurements pre and post anesthesia were only found with USP device; other authors found no significant differences in CCT measurements pre- and post-instillation of tetracaine 0.1% measured with Orbscan. This could be an indication that the measurement system may be sensitive to tear stability, while non-contact optical systems do not detect this difference in CCT. Finally, other authors described a temporal increase of CCT after instillation of 0.4% oxybuprocaine hydrochloride, but that difference close to 8 μm disappeared after 80 s. In conclusion, it can actually be a transient increase in CCT which is only detected by contact instruments, but that increase, even statistically significant, do not appear to be clinically significant.
  3 in total

1.  Evaluation of the comparative effect of tetracaine on central corneal thickness measured by a contact and noncontact pachymeter.

Authors:  Uchechukwu L Osuagwu; Kelechi C Ogbuehi
Journal:  J Ocul Pharmacol Ther       Date:  2012-10-11       Impact factor: 2.671

2.  Comparison of corneal thickness after the instillation of topical anesthetics: proparacaine versus oxybuprocaine.

Authors:  Sang Min Nam; Hyung Keun Lee; Eung Kweon Kim; Kyoung Yul Seo
Journal:  Cornea       Date:  2006-01       Impact factor: 2.651

3.  [Effect of double anaesthetic Colicursi (tetracaine 0.1% and oxybuprocaine 0.4%) on central and paracentral corneal thickness].

Authors:  J A Díaz-Rey; M J Giráldez; C García-Resúa; E Yebra-Pimentel
Journal:  Arch Soc Esp Oftalmol       Date:  2009-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.